Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery
Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery
نویسندگان: رویا صالحی قره ورن , سودابه داوران , فرزانه لطفی پور بناب
کلمات کلیدی: In situ nanogel, dual stimuli responsive,ocular drug delivery, ciprofloxacin,antimicrobial activity, keratitis
نشریه: 18078 , 5 , 32 , 2015
| نویسنده ثبت کننده مقاله |
رویا صالحی قره ورن |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
مرکز تحقیقات کاربردی دارویی |
| کد مقاله |
57549 |
| عنوان فارسی مقاله |
Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery |
| عنوان لاتین مقاله |
Preparation and in vivo evaluation of in situ gel system as dual thermo-/pH-responsive nanocarriers for sustained ocular drug delivery |
| ناشر |
6 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://www.ncbi.nlm.nih.gov/pubmed/26190215 |
| Objective: Ciprofloxacin (CIP) was effective in treating bacterial keratitis. The purpose of this
study was to prepare an effective prolonged-release of CIP by both temperature and
pH-triggered in situ nanogels for the treatment of keratitis. Materials and methods: Poly(Nisopropylacrylamide-
methacrylicacide-vinylpyrrolidone) [P (NIPAAm-MAA-VP)] nanoparticles
was synthesised and used for preparation of CIP-loaded nanogels. Antimicrobial and in vivo
animal studies of the CIP-loaded nanoformulation were performed. Results: Nanoformulation
with a mean particle size between 10 and 50nm and higher than 95% encapsulation efficiency
was obtained. Ciprofloxacin released from the nanoparticles showed an enhanced antibacterial
effect as determined by minimal inhibitory concentrations. In vivo studies demonstrated
reasonable efficacy in severe keratitis using the developed nanoformulation. Conclusions:
Nanoformulation had acceptable efficacy in treating bacterial keratitis in an animal model.
Therefore, the developed system has the potential to be used in localised application for the
treatment of keratitis. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 25-J Microencapsul,salehi, 2015.pdf | 1395/01/14 | 1227868 | دانلود |